Paper
2 July 2001 Targeted Type 1 phototherapeutic agents using azido-peptide bioconjugates
Raghavan Rajagopalan, Samuel I. Achilefu, Hermo N. Jimenez, Elizabeth G. Webb, Michelle A. Schmidt, Joseph E. Bugaj, Richard B. Dorshow
Author Affiliations +
Abstract
Five peptides binding to somatostatin and bombesin receptors were conjugated to 4-azido-2,3,4,6-tetrafluorophenylbenzoic acid, a Type 1 photosensitizer, at the N-terminal position. The receptor affinities were determined by competition binding assay using two different pancreatic tumor cell lines, CA20948 and AR42-J, that expresses somatostatin-2 (SST-2) and bombesin receptors receptively. All compounds exhibited high receptor specificity, i.e., the IC50 values ranged between 1.0 to 64.0 nM. These conjugates may be useful for targeted Type 1 phototherapy via the generation of nitrenes at the cell surfaces expressing these receptors.
© (2001) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Raghavan Rajagopalan, Samuel I. Achilefu, Hermo N. Jimenez, Elizabeth G. Webb, Michelle A. Schmidt, Joseph E. Bugaj, and Richard B. Dorshow "Targeted Type 1 phototherapeutic agents using azido-peptide bioconjugates", Proc. SPIE 4259, Biomarkers and Biological Spectral Imaging, (2 July 2001); https://doi.org/10.1117/12.432494
Lens.org Logo
CITATIONS
Cited by 1 patent.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Receptors

Tissue optics

Oxygen

Phototherapy

Energy transfer

Tumors

Solids

Back to Top